Human Immunodeficiency Virus 1 Positive: Clinical Trials

4 trials for Human Immunodeficiency Virus 1 Positive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Completed 1

Follow Human Immunodeficiency Virus 1 Positive: new trials by email Literature Review of Human Immunodeficiency Virus 1 Positive trials Research Report on Human Immunodeficiency Virus 1 Positive

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection
Laboratory Biomarker Analysis, Pomalidomide - Human Immunodeficiency Virus 1 Positive, Skin Kaposi Sarcoma
Phase 2CompletedAIDS Malignancy Consortium262021-04-262026-04-13
Incidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin America
Medical Chart Review, Survey Administration - HIV Infection, Human Immunodeficiency Virus 1 Positive
CompletedAIDS Malignancy Consortium1752020-01-172023-09-01
Evaluating Quality of Life in Patients With AIDS-Associated Kaposi Sarcoma Treated With Bleomycin and Vincristine
Bleomycin Sulfate, Laboratory Biomarker Analysis, Quality-of-Life Assessment - AIDS-Related Kaposi Sarcoma, Human Immunodeficiency Virus 1 Positive
CompletedAIDS Malignancy Consortium102018-10-102026-02-11
HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection
C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs, Carmustine, Filgrastim - Human Immunodeficiency Virus 1 Positive, Stage I Adult Hodgkin Lymphoma
Phase 1WithdrawnFred Hutchinson Cancer Center2016-08-152018-11-20

Narrower conditions

AIDS-related Kaposi sarcoma (1)  ·  HIV Infections (1)  ·  Hodgkin Disease (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Broader conditions

Immune System Diseases (2)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Bleomycin (1)  ·  Carmustine (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  O(6)-benzylguanine (1)  ·  Vincristine (1)  ·  carmustine, poliferprosan 20 drug combination (1)  ·  ferric pyrophosphate (1)  ·  plerixafor (1)  ·  pomalidomide (1)

Sponsors

AIDS Malignancy Consortium (3)  ·  Fred Hutchinson Cancer Center (1)

Countries

Argentina (1)  ·  Brazil (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Mexico (1)  ·  Tanzania (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Kristin Schroeder (1)  ·  Mazyar Shadman (1)  ·  Nestory Masalu (1)  ·  Robert M Strother (1)  ·  Samantha Vogt, MD, MPH (1)  ·  Susan E. Krown, MD (1)

NIH funding

UM1CA121947 (3), P30CA015704 (1), R01HL116217 (1)